In March 2025, the company declared new programs for the immediate-to-consumer supplying of its Wegovy weight loss drug. The company proven a whole new pharmacy, called NovoCare, which might cost shoppers $499 every month for entry to the drug, a lot less than 50 % the expense of the drug as a result of other pharmaceutical distribution networks.[f